Trial Profile

A Phase 1b study aimed at assessing the efficacy and safety of Purified Exosome Product

Status: Not yet recruiting

Phase of Trial: Phase I

Latest Information Update: 13 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

11 Mar 2025 According to RION Media Release, company announced the enrollment of the first patient in its Phase 1b clinical study evaluating Purified Exosome Product for the treatment of Knee Osteoarthritis.
12 Sep 2024 New trial record
10 Sep 2024 According to RION Media Release, company initiated this Phase 1b clinical trial to assess safety and efficacy signals following treatment with Platelet Exosome Product (PEP) for the management of knee osteoarthritis.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com